These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. 2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor. Pelletier JC; Chengalvala M; Cottom J; Feingold I; Garrick L; Green D; Hauze D; Huselton C; Jetter J; Kao W; Kopf GS; Lundquist JT; Mann C; Mehlmann J; Rogers J; Shanno L; Wrobel J Bioorg Med Chem; 2008 Jul; 16(13):6617-40. PubMed ID: 18511284 [TBL] [Abstract][Full Text] [Related]
5. The role of gonadotropin releasing hormone in normal and pathologic endocrine processes. Rothman MS; Wierman ME Curr Opin Endocrinol Diabetes Obes; 2007 Aug; 14(4):306-10. PubMed ID: 17940457 [TBL] [Abstract][Full Text] [Related]
6. At last, an orally active gonadotropin-releasing hormone antagonist. Paulson RJ Fertil Steril; 2019 Jan; 111(1):30-31. PubMed ID: 30611410 [No Abstract] [Full Text] [Related]
7. Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Engel JB; Schally AV Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):157-67. PubMed ID: 17237842 [TBL] [Abstract][Full Text] [Related]
8. Benzimidazoles as non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 3: Discovery of 1-(1H-benzimidazol-5-yl)-3-tert-butylurea derivatives. Tatsuta M; Kataoka M; Yasoshima K; Sakakibara S; Shogase Y; Shimazaki M; Yura T; Li Y; Yamamoto N; Gupta J; Urbahns K Bioorg Med Chem Lett; 2005 May; 15(9):2265-9. PubMed ID: 15837306 [TBL] [Abstract][Full Text] [Related]
9. Oral delivery of oil-based formulation for a novel synthetic cationic peptide of GnRH (gonadotropin-releasing hormone) antagonist for prostate cancer treatment. Zhang G; Wang T; Gao L; Quan D Int J Pharm; 2013 Jun; 450(1-2):138-44. PubMed ID: 23623791 [TBL] [Abstract][Full Text] [Related]
10. G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: a case for Gnrh, LH, FSH, and GPR54 receptor ligands. Heitman LH; Ijzerman AP Med Res Rev; 2008 Nov; 28(6):975-1011. PubMed ID: 18561294 [TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone (GnRH) analogues and the ovary: do GnRH antagonists destroy primordial follicles? Gupta RK; Flaws JA Fertil Steril; 2005 May; 83(5):1339-42. PubMed ID: 15866566 [TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel, orally active, small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist. Li H; Anderes KL; Kraynov EA; Luthin DR; Do QQ; Hong Y; Tompkins E; Sun ET; Rajapakse R; Pathak VP; Christie LC; Feng J; Vazir H; Castillo R; Gregory ML; Castro M; Nared-Hood K; Paderes G; Anderson MB J Med Chem; 2006 Jun; 49(11):3362-7. PubMed ID: 16722655 [TBL] [Abstract][Full Text] [Related]
13. Syntheses and structure-activity relationship studies of piperidine-substituted quinolones as nonpeptide gonadotropin releasing hormone antagonists. Jiang J; DeVita RJ; Goulet MT; Wyvratt MJ; Lo JL; Ren N; Yudkovitz JB; Cui J; Yang YT; Cheng K; Rohrer SP Bioorg Med Chem Lett; 2004 Apr; 14(7):1795-8. PubMed ID: 15026074 [TBL] [Abstract][Full Text] [Related]
14. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Danforth DR; Arbogast LK; Friedman CI Fertil Steril; 2005 May; 83(5):1333-8. PubMed ID: 15866565 [TBL] [Abstract][Full Text] [Related]
17. Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: a review of their discovery, development, and place in therapy. Moreau JP; Delavault P; Blumberg J Clin Ther; 2006 Oct; 28(10):1485-508. PubMed ID: 17157109 [TBL] [Abstract][Full Text] [Related]
18. Elagolix (Orilissa)--an oral GnRH antagonist for endometriosis pain. Med Lett Drugs Ther; 2018 Sep; 60(1556):158-160. PubMed ID: 30383729 [No Abstract] [Full Text] [Related]
19. Novel follicular-phase gonadotropin-releasing hormone antagonist stimulation protocol for in vitro fertilization in the poor responder. Frankfurter D; Dayal M; Dubey A; Peak D; Gindoff P Fertil Steril; 2007 Nov; 88(5):1442-5. PubMed ID: 17481626 [TBL] [Abstract][Full Text] [Related]
20. Elimination of antibacterial activities of non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists derived from erythromycin A. Randolph JT; Sauer DR; Haviv F; Nilius AM; Greer J Bioorg Med Chem Lett; 2004 Mar; 14(6):1599-602. PubMed ID: 15006412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]